General Information
Version
2.1, 02/28/2008
Revision date
2008-02-28
Product name
Erbitux TM for Injection
Product Synonyms
C225 for Injection, BMS-564717-01 for Injection, Anti-EGfr Chimeric Monoclonal
Chemical name
Anti-EGFr Chimeric Monoclonal Antibody Cetuximab
1.2.1 Relevant identified uses
This material is a finished drug product for patient use. It is a monoclonal antibody used to treat cancer
Emergency telephone
1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
Bristol-Myers Squibb Company
Section 2
Further information
Sodium hydroxide is used for pH adjustment Hydrochloric acid is used for pH adjustment
SECTION 2: Hazards identification
Emergency Overview Appearance liquid clear ; aqueous solution
Hazard statements
CAUTION-SUBSTANCE NOT FULLY TESTED
Precautionary statements
Avoid ingestion, inhalation, skin and eye contact. Wash hands after handling to minimize exposure. Handle as a potentially hazardous material.
Potential health effects
Eyes Not available Skin Not available Ingestion Significant systemic exposure is not expected from this route of exposure. 3. HAZARDS IDENTIFICATION Inhalation Not available target organs Not available Signs and Symptoms Acute: rash, acne, inflammation of the mouth, allergy, weakness, fever, dehydration, nausea, vomiting, diarrhoea, constipation, decreased body weight, headache Environmental Effects Not available
